Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain. [electronic resource]
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Nov 2014
- A530 p. digital